GESTWICKI, Jason

Professor, University of California, San Francisco, Department of Pharmaceutical Chemistry

Statement of interest

The landscape of scientific publishing is undergoing exciting changes, with a push toward increased rigor, transparency and access. At the same time, changing financial incentives and increased competition have placed pressure on the system. I firmly believe that, in this new ecosystem, society journals, such as those supported by the ASBMB, continue to play a critical role.

In our journals, high-quality work, even that performed at the fringes of what is considered trendy, can be communicated in a clear and direct way to the audience(s) that will be most impacted and inspired. However, to maintain this mission, society journals will need to adapt to the changing publishing landscape, while also staying true to their core principles. What are the goals of publishing? To communicate scientific findings? To create learning opportunities for trainees? To inspire others to ask the next questions? All of these answers (and more) can be true.

My own experiences publishing in the Journal of Biological Chemistry have been rewarding because the editors, reviewers and authors have a seemingly common objective. I am pleased to be considered for the ASBMB’s Publications Committee so that I have a chance to continue the work of my predecessors in guiding our society journals.

Education and training

B.S., Chemistry, State University of New York at Fredonia, 1997
Ph.D., Biochemistry, University of Wisconsin–Madison, 2002
Postdoctoral training, Stanford University, 2002–2005

Awards and honors

National Science Foundation, 2009
Fellow, American Association for the Advancement of Science, 2012
Fellow, Cell Stress Society International, 2018
E. Thomas Kaiser Award, Protein Society, 2023

Experience

Scientific advisory board member, Chemical Biology & Drug Design, 2007–present
Scientific advisory board member, Journal of Medicinal Chemistry, 2012–present
Associate editor, ACS Chemical Biology, 2014–present
Scientific advisory board member, Cell Chemical Biology, 2015–present